Author

K. Khunti

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Increasing burden of multiple long-term conditions and mortality risk following COVID-19 diagnosis: a national cohort study of one million adults with cardiovascular disease in England.

BACKGROUND Individuals with cardiovascular disease (CVD) experienced high mortality during coronavirus disease 2019 (COVID-19), yet most live with multiple long-term conditions (MLTCs). We examined the association between MLTCs burden and mortality following COVID-19 among people with CVD. METHODS In this population-...

Yogini V. Chudasama, S. Shabnam, K. Khunti et al. · Journal of public health · 0 citations

Aug 2026

Association of Lipid Ratios With Cardiovascular Outcomes in Type 2 Diabetes: A Population Cohort Study.

AIMS To identify low- and high-risk intervals for major adverse cardiovascular events (MACE) and all-cause mortality according to lipid ratios in adults with Type 2 diabetes mellitus (T2DM), stratified by sex. MATERIALS AND METHODS We used primary care electronic health records from the Spanish National Health Servic...

E. Carretero-Anibarro, J. Quesada, Manuel A. Ruiz-Quintero et al. · Diabetes, obesity and metabo... · 0 citations

Review Open access Jul 2026

Comparative effects of drugs for adults with overweight or obesity: systematic review and network meta-analysis

Moderate to high certainty evidence supports discontinuation of drugs for adults with overweight or obesity because of adverse events to be highest with orforglipron, naltrexone-bupropion, liraglutide, phentermine-topiramate, CagriSema, and oral semaglutide.

Kai-Lei Nong, Qingyang Shi, Xinran Xie et al. · British medical journal · 5 citations